Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abrupt cessation versus 8-hour weaning of unfractionated heparin after stopping CVVH in ICU patients
NL-OMON21886Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of heparin in thrombosis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Activated partial thromboplastin time, Anti-factor Xa activity and 12 more. Planned start Jun 2006; status: not yet recruiting.
02
Drugs
heparin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NL-OMON21886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21886.